Patents by Inventor Olivier David

Olivier David has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140187516
    Abstract: S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
    Type: Application
    Filed: February 10, 2014
    Publication date: July 3, 2014
    Applicant: NOVARTIS AG
    Inventors: Craig BOULTON, Pascale BURTIN, Olivier DAVID, Ana de VERA, Thomas DUMORTIER, Irene HUNT, Robert SCHMOUDER
  • Publication number: 20140148415
    Abstract: S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
    Type: Application
    Filed: January 31, 2014
    Publication date: May 29, 2014
    Applicant: NOVARTIS AG
    Inventors: Robert SCHMOUDER, Thomas DUMORTIER, Olivier DAVID, Michael LOOBY
  • Publication number: 20140066657
    Abstract: S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage
    Type: Application
    Filed: September 6, 2013
    Publication date: March 6, 2014
    Applicant: Novartis AG
    Inventors: Robert Schmouder, Thomas Dumortier, Olivier David, Michael Looby
  • Patent number: 8652094
    Abstract: The present invention relates to a syringe (20) defining a reservoir (21) for containing a liquid and comprising an end-piece (10) encompassing a channel (11) providing a passageway for the transfer of the said liquid, characterized in that the said channel (11) comprises two portions, a first portion (12) and a second portion (13), the said first portion (12) extending from the free distal end (14) of the end-piece (10) in the direction of the reservoir (21), and the said second portion (12) extending between the first portion (12) of the channel (11) and the proximal end (15) of the end-piece (10) and connecting the said first portion (12) to the reservoir, the said first portion (12) having an average diameter that is greater than the average diameter of the said second portion (13).
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: February 18, 2014
    Assignee: Becton Dickinson France
    Inventors: Olivier David, Emeric Mermet
  • Publication number: 20130218336
    Abstract: A method for handling of a first robotized mobile machine moving in a congested working environment under the control of a second robotized mobile machine, providing the operator, in real time, with a relevant view of the working scene, even if an object intrudes into the field of view of the camera and thereby obscures the operator's view. This method is based on use of properties of a physics engine of the constraint resolution type. For each object in the scene, the physics engine has a physical representation of said object in the form of a mesh. The engine calculates a wrench on the basis of the respective positions and velocities of two objects. In case of a collision between the manipulator and a fixed object in the scene, the engine determines the wrench to be applied to the manipulator in order to make it avoid the object.
    Type: Application
    Filed: February 11, 2011
    Publication date: August 22, 2013
    Inventors: Olivier David, Yvan Measson, François-Xavier Russotto
  • Publication number: 20120264719
    Abstract: S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
    Type: Application
    Filed: September 20, 2010
    Publication date: October 18, 2012
    Inventors: Craig Boulton, Pascale Burtin, Olivier David, Ana de Vera, Thomas Dumortier, Irene Hunt, Robert Schmouder
  • Publication number: 20110257133
    Abstract: S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
    Type: Application
    Filed: December 21, 2009
    Publication date: October 20, 2011
    Inventors: Robert Schmouder, Thomas Dumortier, Olivier David, Michael Looby
  • Publication number: 20110152380
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a pediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: June 19, 2009
    Publication date: June 23, 2011
    Inventors: John M. Kovarik, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson, Thomas Bouillon
  • Publication number: 20110130717
    Abstract: The present invention relates to a syringe (20) defining a reservoir (21) for containing a liquid and comprising an end-piece (10) encompassing a channel (11) providing a passageway for the transfer of the said liquid, characterized in that the said channel (11) comprises two portions, a first portion (12) and a second portion (13), the said first portion (12) extending from the free distal end (14) of the end-piece (10) in the direction of the reservoir (21), and the said second portion (12) extending between the first portion (12) of the channel (11) and the proximal end (15) of the end-piece (10) and connecting the said first portion (12) to the reservoir, the said first portion (12) having an average diameter that is greater than the average diameter of the said second portion (13).
    Type: Application
    Filed: May 27, 2009
    Publication date: June 2, 2011
    Applicant: BECTON DICKINSON FRANCE
    Inventors: Olivier David, Emeric Mermet
  • Publication number: 20100160259
    Abstract: S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage
    Type: Application
    Filed: December 21, 2009
    Publication date: June 24, 2010
    Inventors: Robert Schmouder, Thomas Dumortier, Olivier David, Michael Looby
  • Publication number: 20040099175
    Abstract: The train (1) of modules (2 to 6) that forms the robot comprises springs (38) to connect the successive modules together enabling curvature of the train in the bends of a pipe. However, cables (41) bring the modules together by compressing the springs when they are pulled, until the conical end faces (39, 40) are engaged in each other; the train is made rigid and can be immobilised inside the pipe to perform different types of machining operations, including welding or cutting joints between successive pipes in the pipework.
    Type: Application
    Filed: July 15, 2003
    Publication date: May 27, 2004
    Inventors: Yann Perrot, Olivier David